Sialylation of immunoglobulin E is a determinant of allergic pathogenicity

Kai-Ting C. Shade, Michelle E. Conroy, Nathaniel Washburn, Maya Kitaoka, Daniel J. Huynh, Emma Laprise, Sarita U. Patil, Wayne G. Shreffler and Robert M. Anthony ()
Additional contact information
Kai-Ting C. Shade: Harvard Medical School
Michelle E. Conroy: Harvard Medical School
Nathaniel Washburn: Momenta Pharmaceuticals Inc
Maya Kitaoka: Harvard Medical School
Daniel J. Huynh: Harvard Medical School
Emma Laprise: Harvard Medical School
Sarita U. Patil: Harvard Medical School
Wayne G. Shreffler: Harvard Medical School
Robert M. Anthony: Harvard Medical School

Nature, 2020, vol. 582, issue 7811, 265-270

Abstract: Abstract Approximately one-third of the world’s population suffers from allergies1. Exposure to allergens crosslinks immunoglobulin E (IgE) antibodies that are bound to mast cells and basophils, triggering the release of inflammatory mediators, including histamine2. Although IgE is absolutely required for allergies, it is not understood why total and allergen-specific IgE concentrations do not reproducibly correlate with allergic disease3–5. It is well-established that glycosylation of IgG dictates its effector function and has disease-specific patterns. However, whether IgE glycans differ in disease states or affect biological activity is completely unknown6. Here we perform an unbiased examination of glycosylation patterns of total IgE from individuals with a peanut allergy and from non-atopic individuals without allergies. Our analysis reveals an increase in sialic acid content on total IgE from individuals with a peanut allergy compared with non-atopic individuals. Removal of sialic acid from IgE attenuates effector-cell degranulation and anaphylaxis in several functional models of allergic disease. Therapeutic interventions—including removing sialic acid from cell-bound IgE with a neuraminidase enzyme targeted towards the IgE receptor FcεRI, and administering asialylated IgE—markedly reduce anaphylaxis. Together, these results establish IgE glycosylation, and specifically sialylation, as an important regulator of allergic disease.

Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41586-020-2311-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:582:y:2020:i:7811:d:10.1038_s41586-020-2311-z

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-020-2311-z

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().